NCT01551836View on ClinicalTrials.gov

At What Time Therapeutic Plasma Concentrations of Paracetamol Are Achieved in Two Marketed Formulations

PHASE1CompletedINTERVENTIONAL

Enrollment

12

Participants

Timeline

Start Date

June 30, 2009

Primary Completion Date

June 30, 2009

Study Completion Date

June 30, 2009

Conditions

Healthy Volunteer

Interventions

DRUG

Paracetamol formulation 1

formulation 1

DRUG

Paracetamol formulation 2

Formulation 2

Trial Locations (1)

BT9 6AD

GSK Investigational Site, Belfast

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY